Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2008
11/26/2008CN100436420C 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
11/26/2008CN100436415C Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
11/26/2008CN100436407C Preparation of piper laetispicum effective part and its use in medical therapy and health field
11/26/2008CN100435814C Scullcap stem and leaf injection powder and its preparing method
11/26/2008CN100435813C Series medicines for treating headache
11/26/2008CN100435792C Application of butylbenzene phthalein homolog in preparation of medicine for treating cerebral ischemia disease
11/26/2008CN100435656C Fruit and/or vegetable derived composition
11/25/2008US7456291 Use of a vitamin combination for the treatment of primary headaches
11/25/2008US7456278 Lactams substituted by cyclic succinates as inhibitors of Aβ protein production
11/25/2008US7456269 Alzheimer's disease secretase, APP substrates thereof, and uses thereof
11/25/2008US7456255 Nogo receptor homologs that decrease inhibition of axonal elongation
11/25/2008US7456200 Compounds
11/25/2008US7456198 Useful in the treatment of chronic and acute pain.
11/25/2008US7456192 3β-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof
11/25/2008US7456190 autoimmune disease; antiinflammatory agents; bone disorders; central nervous system disorders; cardiovascular disorders; Alzheimer's disease; antihistamines; antiallergens
11/25/2008US7456186 Diphenylimidazopyrimidines as inhibitors of β-secretase
11/25/2008US7456182 Phenylpiperazines
11/25/2008US7456177 Heteroaryl fused azapolycyclic compounds which bind to neuronal nicotinic acetylcholine specific receptor sites, and which are useful in modulating cholinergic function, for for reducing nicotine addiction or aiding in the cessation or lessening of tobacco use in a mammal, therapy
11/25/2008US7456172 Succinoylamino benzodiazepines as inhibitors of Aβ protein production
11/25/2008US7456171 Nicotinic ligands; treatment of nervous system disorders, neurodegenerative disorders, psychological disorders, and tobacco, drug and alcohol withdrawal symptoms
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456163 Macrocycles useful in the treatment of alzheimer's disease
11/25/2008US7456162 Benzofuran derivatives, their production and use
11/25/2008US7456154 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/25/2008US7455855 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance
11/25/2008US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2449922C Pharmaceutical composition for therapy of interstitial cystitis
11/25/2008CA2414146C Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
11/25/2008CA2382588C Polymorphs of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
11/25/2008CA2376791C Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/25/2008CA2367666C Method of treating eating disorders
11/25/2008CA2348390C Compositions for the treatment and prevention of neurological and pathopsychological diseases
11/25/2008CA2224369C Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use
11/20/2008WO2008141321A1 Methods and device to neutralize soluble toxic agents in the brain
11/20/2008WO2008141249A1 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
11/20/2008WO2008141239A1 Imidazol [1,2-a] pyridines and related compounds with activity at cannabinoid cb2 receptors
11/20/2008WO2008141097A2 Stereoisomers propofol therapeutic compounds
11/20/2008WO2008141057A1 Deuterated pimavanserin 1- (4-flu0r0benzyl) -3- (4-isobutoxybenzyl) -1- ( l-methyl-piperidin-4-yl) -urea
11/20/2008WO2008141033A1 Substituted naphthalenes
11/20/2008WO2008141020A1 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists
11/20/2008WO2008140421A2 Heterocycloalkyl substituted pyrimidine derivatives
11/20/2008WO2008140420A2 Pyrimidine derivatives
11/20/2008WO2008140419A2 Pyridyl substituted pyrimidine derivatives
11/20/2008WO2008140373A1 A liquid formulation for administering nicotine
11/20/2008WO2008140372A1 Coated oral nicotine formulation buffered with amino acid
11/20/2008WO2008140371A1 Oral nicotine formulation buffered with amino acid
11/20/2008WO2008140335A2 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
11/20/2008WO2008140259A1 A composition for regulating cellular senescence comprising n-[2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide
11/20/2008WO2008140198A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008WO2008140051A1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/20/2008WO2008139987A1 G-protein-conjugated receptor agonist
11/20/2008WO2008139984A1 Cinnamide compounds for dementia
11/20/2008WO2008139894A1 Nitrogenated aromatic 6-membered ring derivative, and pharmaceutical agent comprising the same
11/20/2008WO2008139879A1 G protein-coupled receptor inhibitor and pharmaceutical product
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008139235A2 Novel piperazine salts as d3/d2 antagonists
11/20/2008WO2008138943A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies
11/20/2008WO2008138920A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008WO2008138917A1 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
11/20/2008WO2008138905A1 Use of a monoterpene to treat or prevent stress
11/20/2008WO2008138874A1 Process for preparing (s)-pregabalin by optical resolution of racemic pregabalin
11/20/2008WO2008138753A1 Hetarylanilines as modulators for amyloid beta
11/20/2008WO2008138605A2 Method for producing n-methylnaltrexone bromide
11/20/2008WO2008138571A1 Probiotic bacteria containing oral dosage form
11/20/2008WO2008138558A1 Axomadol for treating pain from arthritis
11/20/2008WO2008138383A1 Method for the production of n-methyl naltrexone bromide
11/20/2008WO2008138200A1 Nmda and mc receptor antagonists exhibiting neuroprotective and memory enhancing activities
11/20/2008WO2008113559A3 Indolizines and aza-analog derivatives thereof as cns active compounds
11/20/2008WO2008097897A9 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1)
11/20/2008WO2008092591A3 Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent
11/20/2008WO2008065408A3 Modulation of prostaglandin/cyclooxygenase metabolic pathways
11/20/2008WO2008062453B1 Composition containing nicotine base aromatic oils and alkyl salicylate for the delivery of nicotine base in vapour form
11/20/2008WO2008045641A3 Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent
11/20/2008WO2008033299A3 Use of n-containing spirocompounds for the enhancement of cognitive function
11/20/2008WO2007138041A8 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
11/20/2008WO2007138040A8 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
11/20/2008WO2007070701A3 Compositions and methods for preserving brain function
11/20/2008US20080289058 Targeted delivery of glycine receptors to excitable cells
11/20/2008US20080287866 Methods and compositions for the treatment of pain
11/20/2008US20080287550 Sertraline hydrochloride form II and methods for the preparation thereof
11/20/2008US20080287548 Compositions and Methods For Inhibiting an Isoform of Human Manganese Superoxide Dismutase
11/20/2008US20080287547 Glycine Transport Inhibitors
11/20/2008US20080287545 Use of Peptide Compounds For the Prophylaxis and Treatment of Chronic Headache
11/20/2008US20080287542 Novel Isovaleramide Forms, Compositions Thereof, and Related Methods of Use
11/20/2008US20080287532 Oxacyclopentene-2 derivatives
11/20/2008US20080287528 Therapeutic methods and compositions involving isoflavones
11/20/2008US20080287523 Pyrrolidin-3-Yl Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
11/20/2008US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
11/20/2008US20080287521 Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1)
11/20/2008US20080287519 Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
11/20/2008US20080287518 Use of a Benzoyl Derivative of 3-Aminocarbazole For the Treatment of a Disorder Associated With the Production of Prostaglandin E2 (Pge2)
11/20/2008US20080287517 Pyrazole Derivatives as Cb1 Modulators
11/20/2008US20080287510 Novel compounds as cannabinoid receptor ligands
11/20/2008US20080287501 Therapeutic uses of an insulin secretion enhancer
11/20/2008US20080287500 Diastereomers of 4-aryloxy-3-hydroxypiperidines
11/20/2008US20080287497 Transdermal methods and systems for the delivery of anti-migraine compounds
11/20/2008US20080287495 Novel benzo[d][1,3]-dioxol derivatives
11/20/2008US20080287492 Alkylpyridyl Quinolines as Nk3 Receptor Modulators
11/20/2008US20080287491 Tetrahydroquinoline Derivative for Treating Nicotine Craving
1 ... 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 ... 1833